yanke
rapidli
find
benefit
telephon
newli
made
grandmamma
told
recent
awaken
bell
midnight
told
inexperienc
daughter
babi
croup
shall
grandmamma
repli
would
call
famili
doctor
would
minut
grandmamma
woke
doctor
told
terribl
news
turn
ask
put
telephon
commun
anxiou
mamma
lift
child
telephon
let
hear
cough
command
child
lift
cough
croup
declar
declin
leav
hous
small
matter
advis
grandmamma
also
stay
bed
anxieti
quiet
trio
settl
happi
concern
infraglott
bronchial
infect
sourc
anxieti
lost
sleep
mani
children
parent
physician
long
advent
telephon
annual
incid
lower
respiratori
tract
infect
children
younger
year
old
exce
million
unit
despit
frequenc
cf
infect
often
common
nonspecif
clinic
symptomatolog
variabl
sever
chang
epidemiolog
time
contribut
understand
misunderstand
disord
anxieti
rel
describ
open
passag
poignant
remind
diagnosi
diphtherit
croup
time
carri
mortal
around
simpl
definit
laryng
tracheiti
bronchiti
combin
term
e
g
laryngotrach
laryngotracheobronch
ltb
tracheobronch
repres
inflammatori
condit
part
part
ra
basic
form
specif
caus
infecti
noninfecti
impli
term
respiratori
tract
larynx
bronchu
compos
connect
tissu
cartilag
muscl
intrins
extrins
striat
smooth
mucosa
along
vascular
lymphat
nervou
infraglott
respiratori
tract
includ
element
inferior
vocal
fold
adjac
apparatu
trachea
bronchi
larynx
complex
structur
compos
interact
element
cartilag
muscl
function
includ
phonat
air
passag
protect
airway
trachea
compos
singl
complet
cartilagin
ring
cricoid
multipl
incomplet
ring
along
loos
connect
tissu
conduct
portion
airway
undergo
multipl
gener
arbor
trachea
termin
bronchiol
includ
primari
main
stem
lobar
segment
subsegment
bronchi
sever
gener
bronchiol
remaind
airway
respiratori
portion
includ
addit
divis
respiratori
bronchiol
alveoli
variat
arbor
secondari
asymmetr
dichotom
branch
result
threefold
differ
airway
gener
basal
apic
e
g
e
n
epithelium
line
airway
chang
stratifi
squamou
ciliat
epithelium
around
base
epiglotti
stratifi
squamou
epithelium
cover
epiglotti
vocal
cord
ciliat
epithelium
continu
base
epiglotti
respiratori
bronchiol
mucou
product
achiev
goblet
cell
submucos
gland
interspers
among
columnar
cell
movement
cilia
propel
mucu
particul
matter
includ
dust
bacteria
toward
open
oropharynx
descent
respiratori
tract
amount
cartilag
decreas
wherea
proport
smooth
muscl
increas
absenc
cartilag
submucos
gland
differenti
bronchiol
structur
open
environ
respiratori
tract
must
protect
multitud
environment
insult
exposur
includ
chang
temperatur
humid
well
larg
small
particl
e
g
aspir
microorgan
airborn
toxin
smoke
noxiou
gase
defens
respiratori
tract
provid
combin
physic
forc
physiolog
system
inhal
particl
deposit
throughout
airway
base
size
larger
particl
pm
deposit
turbul
nasal
passag
wherea
smaller
particl
deposit
mucou
layer
ciliat
infraglott
addit
hold
onto
deposit
particl
mucou
blanket
provid
barrier
epitheli
line
airway
alter
temperatur
humid
cilia
serv
propel
mucu
trap
particl
toward
oropharynx
cough
result
stimul
irrit
receptor
locat
throughout
upper
uri
lower
respiratori
tract
cough
import
adjunct
clear
particl
final
cellular
humor
immun
involv
respiratori
tract
defens
immun
cell
eg
macrophag
circul
along
mucociliari
blanket
cell
remov
small
particl
phagocytosi
wherea
immunoglobulin
especi
iga
provid
addit
protect
infecti
agent
infect
varieti
microbiolog
agent
produc
similar
pathophysiolog
effect
ciliat
epithelium
respiratori
tract
effect
includ
loss
ciliari
function
releas
inflammatori
mediat
chang
mucou
product
qualiti
edema
cell
death
chang
vari
degre
depend
etiolog
agent
respons
respiratori
manifest
infraglott
bronchial
infect
specif
clinic
manifest
elicit
may
reflect
site
predomin
inflamm
although
differ
agent
may
produc
similar
manifest
singl
agent
act
differ
host
may
respons
rang
diseas
state
infect
influenza
viru
may
result
inflamm
throughout
respiratori
tract
uri
infect
otiti
media
croup
bronchiol
may
produc
sign
symptom
outsid
respiratori
tract
studi
children
report
half
hospit
influenza
secondari
lower
respiratori
tract
diseas
organ
system
includ
central
nervou
gastrointestin
show
signific
involv
affect
n
v
da
l
varieti
system
nomenclatur
use
classifi
infraglott
bronchial
infect
system
may
base
etiolog
eg
infecti
noninfecti
specif
microbiolog
e
g
viral
bacteri
forth
anatom
eg
laryng
laryngotrach
laryngotracheobronchi
tracheobronchi
bronchial
forth
tempor
eg
acut
chronic
recurr
featur
must
understood
howev
divis
often
may
appear
arbitrari
indistinct
appli
clinic
set
anatom
classif
may
take
account
spread
inflamm
infect
among
adjac
element
respiratori
tract
ie
laryng
exist
separ
tracheiti
tracheiti
bronchiti
bronchiti
bronchiol
bronchiol
pneumon
pneumonia
often
difficult
clinic
predict
extent
involv
respiratori
tract
likewis
classif
specif
microbiolog
categori
may
difficult
accomplish
histori
clinic
examin
alon
multipl
infecti
agent
result
similar
sign
symptom
wherea
singl
agent
caus
spectrum
ill
virus
parainfluenza
influenza
respiratori
syncyti
viru
rsv
caus
inflamm
throughout
respiratori
tract
without
consider
classif
system
practic
purpos
follow
section
focus
acut
infraglott
specif
viral
croup
bacteri
tracheiti
acut
bronchial
infect
l
od
croup
croup
syndrom
evolv
descript
term
diagnosi
encompass
sever
distinct
disord
share
degre
upper
airway
inflamm
obstruct
croup
syndrom
recent
refer
viral
croup
epiglott
bacteri
tracheiti
earli
laryng
diphtheria
lead
seriou
infect
larynx
infraglott
airway
croup
true
croup
becom
synonym
diphtherit
earli
term
croup
expand
diphtheria
includ
infect
larynx
infraglott
airway
ie
supraglottitisepiglott
well
subglott
infect
one
hundr
year
blaud
initi
descript
nondiphtherit
croup
nondiphtherit
infect
replac
diphtherit
caus
upper
airway
obstruct
describ
acut
bacteri
ltb
distinct
clinic
entiti
nl
r
provid
one
earliest
descript
haernophilu
type
b
epiglott
supraglott
year
later
nonbacteri
ie
viral
caus
croup
suspect
first
half
centuri
belief
base
lack
elev
white
blood
cell
wbc
count
milder
clinic
cours
inabl
isol
bacteri
organ
patient
manner
classifi
major
croup
case
seen
new
hospit
viru
croup
c
h
n
ok
l
credit
first
isol
viral
agent
cytopathogen
myxoviru
refer
croupassoci
viru
patient
croup
use
tissu
cultur
techniqu
later
half
centuri
report
viral
agent
becam
commonplac
bacteri
ltb
seem
disappear
reason
behind
shift
unknown
although
improv
viral
cultur
techniqu
reduct
actual
incid
bacteri
infraglott
infect
possibl
caus
chang
organ
virul
host
factor
antibiot
usag
immun
may
respons
recent
year
term
croup
becom
synonym
gener
selflimit
viral
infect
subglott
stedman
medic
defin
croup
laryngotracheobronch
infant
young
children
caus
parainfluenza
virus
bacteri
caus
airway
obstruct
forgotten
aggress
therapi
case
typic
requir
howev
addit
epiglott
report
bacteri
infraglott
infect
eg
bacteri
tracheiti
reemerg
pediatr
otolaryngolog
literatur
sinc
exact
frequenc
viral
croup
gener
popul
known
like
mani
milder
episod
result
direct
physician
contact
ie
mild
case
may
treat
home
without
health
care
contact
follow
advic
given
telephon
good
epidemiolog
data
howev
exist
children
evalu
outpati
denni
et
collect
case
privat
practic
pediatr
group
chapel
hill
north
carolina
record
reveal
instanc
croup
case
lower
respiratori
tract
infect
report
period
incid
croup
vari
age
case
report
first
month
life
follow
increas
incid
first
year
life
peak
incid
per
children
per
year
boy
per
children
per
year
girl
age
group
year
age
rate
decreas
case
uncommon
schoolag
children
case
occur
age
group
children
younger
year
gender
differ
note
age
group
overal
ratio
boy
girl
l
higher
incid
boy
greatest
second
month
life
l
decreas
almost
even
ratio
age
group
children
older
year
old
l
cluster
croup
case
fall
winter
septemberdecemb
peak
novemb
mirror
season
pattern
respiratori
virus
fall
peak
appear
coincid
parainfluenza
viru
infect
winter
peak
rsv
infect
chapel
hill
experi
mix
infect
uncommon
virtual
patient
croup
sole
diagnosi
although
associ
tracheobronch
wheez
also
p
n
em
n
similar
epidemiolog
data
gather
prepaid
medic
care
group
puget
sound
seattl
washington
group
report
data
case
croup
occur
children
younger
year
old
pattern
age
gender
season
distribut
similar
seen
chapel
hill
group
incid
croup
puget
sound
howev
report
chapel
reason
differ
two
group
unknown
although
cite
unspecifi
procedur
differ
spasmod
croup
recurr
croup
nocturn
croup
catarrh
laryng
stridul
croup
laryngismu
stridulu
term
use
describ
entiti
entiti
share
mani
featur
viral
croup
may
differ
pathophysiolog
typic
viral
case
classic
find
croupi
cough
inspiratori
stridor
spasmod
croup
tradit
differenti
viral
croup
absenc
fever
characterist
onset
addit
author
requir
viral
uri
symptom
absent
make
diagnosi
spasmod
croup
although
other
report
symptom
may
preced
episod
spasmod
ongo
debat
whether
spasmod
croup
viral
croup
separ
condit
whether
repres
differ
part
spectrum
e
ae
theori
concern
caus
spasmod
croup
includ
muscl
spasm
allergi
viral
infect
descript
laryngoscopi
spasmod
croup
report
pale
wateri
edema
contrast
inflammatori
edema
present
viral
croup
although
treatment
spasmod
croup
gener
viral
spasmod
croup
gener
consid
less
sever
may
respons
humidif
perceiv
differ
spasmod
viral
croup
failur
distinguish
two
condit
consist
critic
therapeut
trial
individu
experi
multipl
episod
croup
like
spasmod
croup
evid
suggest
recurr
croup
differ
typic
viral
croup
zach
et
defin
condit
repeat
episod
bark
cough
inspiratori
stridor
often
occur
night
last
hour
descript
consist
recurr
spasmod
croup
rather
separ
episod
viral
croup
studi
report
surprisingli
high
rate
recurr
croup
includ
one
studi
sweden
report
children
recurr
croup
episod
episod
episod
children
recurr
may
frequent
allerg
symptom
eczema
urticaria
asthma
hay
fever
histori
abnorm
allergi
test
pulmonari
function
test
includ
histamin
inhal
ige
antibodi
level
report
patient
recurr
croup
associ
croup
asthma
support
higher
preval
croup
children
asthma
compar
control
versu
higher
incid
airway
hyperreact
children
previous
hospit
microbiolog
viral
croup
well
establish
studi
outpati
inpati
popul
parainfluenza
type
virus
commonli
identifi
agent
repres
half
isol
mani
u
e
data
chapel
hill
parainfluenza
made
isol
individu
croup
parainfluenza
viru
type
particularli
like
produc
symptom
croup
affect
patient
respect
rsv
repres
isol
influenza
type
b
repres
littl
isol
rel
frequenc
specif
infecti
agent
caus
croup
vari
age
child
parainfluenza
common
agent
age
group
wherea
rsv
occur
younger
children
influenza
mycoplasma
present
children
older
year
follow
larg
outbreak
measl
occur
unit
state
late
sever
group
report
common
occurr
croup
patient
three
retrospect
studi
report
frequenc
rang
combin
inpatientoutpati
hospit
patient
case
viral
croup
usual
begin
sign
symptom
mild
viral
uri
rhinorrhea
mild
fever
sore
throat
c
u
within
hour
day
evid
upper
airway
obstruct
appear
hoars
cri
barki
describ
like
seal
bark
croupi
cough
inspiratori
stridor
hallmark
croup
degre
respiratori
distress
may
vari
mild
sever
tachypnea
subcost
suprastern
retract
decreas
air
entri
commonli
report
restless
cyanosi
marker
hypoxemia
result
sever
croup
virus
respons
croup
caus
respiratori
tract
diseas
wheez
crackl
also
heard
occasion
infecti
noninfecti
entiti
mimic
viral
infecti
caus
includ
epiglott
bacteri
tracheiti
diphtheria
peritonsillar
abscess
retropharyng
cellul
abscess
noninfecti
caus
includ
foreign
intrins
extrins
compress
lymph
node
neoplasm
vascular
structureshemangioma
vascular
ring
sling
masseslaryng
polyp
papilloma
subglott
web
vocal
cord
paralysi
allerg
condit
angioneurot
edema
anaphylaxi
trauma
burn
also
produc
manifest
upper
airway
major
case
classic
symptom
mild
natur
probabl
littl
requir
diagnost
evalu
beyond
histori
physic
ea
n
n
signific
histor
risk
factor
chronic
lung
diseas
eg
prematur
subglott
narrow
eg
airway
intub
immunodefici
primari
care
physician
typic
case
croup
clinic
diagnosi
rather
patholog
histolog
anatom
microbiolog
diagnosi
goal
addit
test
rule
worrisom
caus
diagnosi
viral
croup
doubt
ill
sever
toxic
child
influenc
like
caus
well
appropri
diagnost
evalu
therapi
children
suspect
epiglott
otherwis
risk
impend
airway
obstruct
manag
control
set
individu
skill
airway
manag
patient
crucial
delay
caus
addit
diagnost
maneuv
minim
complet
discuss
includ
laboratori
cost
outpati
lab
univers
california
san
francisco
nonspecif
blood
test
wbc
count
differentialwbc
cost
creactiv
protein
crpicrp
cost
erythrocyt
sediment
rateerythrocyt
sediment
rate
cost
may
elev
number
acut
infecti
process
offer
littl
evalu
patient
although
studi
use
crp
specif
croup
report
result
mix
one
studi
n
patient
hospit
epiglott
spasmod
croup
acut
laryngotrach
report
crp
mgl
made
spasmod
croup
unlik
increas
likelihood
nineteen
percent
patient
diagnos
acut
laryngotrach
crp
mgl
howev
larger
studi
n
hospit
children
middl
lower
respiratori
tract
infect
half
patient
bacteria
alon
bacteri
viral
infect
crp
mgl
wherea
patient
viral
infect
alon
crp
microbiolog
studi
eg
gram
stain
cultur
rapid
antigen
detect
studi
serolog
help
identifi
specif
caus
although
result
unlik
alter
manag
typic
respiratori
specimen
obtain
sputum
product
nasal
wash
current
univers
california
san
francisco
rapid
antigen
test
perform
nasal
wash
detect
parainfluenza
type
rsv
adenoviru
influenza
viru
titer
pair
acut
convalesc
sera
also
obtain
virus
mycoplasma
pneumonia
per
pair
specimen
similarli
radiolog
studi
usual
necessari
make
diagnosi
viral
croup
inform
survey
pediatrician
n
present
scenario
patient
typic
viral
croup
howev
answer
would
alway
obtain
rentgenogram
comparison
one
neck
roentgenogram
obtain
patient
hospit
croup
perform
later
neck
roentgenogram
shown
high
sensit
specif
laryngotracheobronch
adequ
studi
interpret
experienc
correl
radiolog
find
clinic
outcom
howev
although
uninterpret
film
associ
increas
clinic
frequenc
roentgenogram
obtain
like
depend
clinic
set
frequenc
croup
encount
confid
physician
make
clinic
diagnosi
plain
film
neck
anteroposterior
ap
lateralcost
help
confirm
diagnosi
laryngotrach
air
trap
dilat
hypopharynx
steepl
sign
secondari
subglott
narrow
help
rule
epiglott
thumb
sign
thicken
aryepiglott
fold
retropharyng
abscess
radioopaqu
foreign
bodi
chest
radiograph
ap
lateralcost
may
show
steepl
sign
ap
view
roentgenogram
obtain
includ
decubitu
film
expiratoryinspiratori
film
foreign
bodi
aspir
suspect
degre
respiratori
distress
acut
laryngotrach
rang
minim
sever
care
physic
examin
determin
degre
distress
well
detect
evid
fatigu
croup
score
system
devis
serv
patient
care
research
purpos
set
croup
score
attempt
creat
object
measur
diseas
sever
allow
comparison
serial
assess
ideal
score
assist
quantifi
respiratori
distress
select
initi
therapi
determin
respons
therapi
requir
addit
therapi
eventu
determin
patient
disposit
discharg
admiss
exampl
one
score
system
shown
tabl
commonli
use
score
yt
e
includ
color
presenc
absenc
cyanosi
air
entri
normal
vari
degre
impair
retract
normal
vari
degre
sever
level
conscious
includ
restless
disori
depress
sever
stridor
presenc
stridor
rest
indic
highest
sever
report
addit
physic
examin
noninvas
techniqu
use
assess
patient
croup
puls
oximetri
report
detect
hypoxemia
earlier
clinic
examin
e
g
cyanosi
bradycardia
one
studpo
patient
upper
airway
obstruct
admit
pediatr
intens
care
unit
show
good
correl
puls
oximetri
arteri
blood
ga
satur
howev
anoth
report
poor
correl
oxygen
satur
puls
oximetri
respiratori
rate
durat
hospit
problem
oximetri
read
attribut
artifact
creat
patient
movement
light
incorrect
sensor
gener
although
puls
oximetri
potenti
use
adjunct
substitut
serial
observ
experienc
health
care
provid
transcutan
carbon
dioxid
monitor
use
one
studi
patient
sever
croup
monitor
author
suggest
techniqu
may
use
monitor
patient
select
patient
requir
intub
numer
therapi
histor
advoc
treatment
croup
literatur
rife
therapi
includ
bleed
leech
soap
sud
enema
alcohol
bath
ice
cap
nose
drop
sed
humidif
hydrat
expector
eg
ipecac
antihistamin
cough
suppress
corticosteroid
adrenerg
gn
therapi
abandon
persist
despit
littl
evid
valu
other
remain
controversi
despit
focu
substanti
clinic
r
ee
r
c
h
use
hydrat
humidif
advoc
decad
treatment
davison
credit
one
first
recommend
use
humidifi
steam
gener
bath
shower
croup
kettl
croup
tent
suggest
techniqu
gener
moistur
techniqu
includ
hang
wet
linen
room
breath
moisten
humidif
may
prevent
dri
mucou
membran
loosen
thicken
secret
lessen
irrit
although
exact
mechan
unknown
addit
humidif
could
reduc
insens
water
loss
act
receptor
larynx
reduc
respiratori
rate
humidif
consid
mainstay
therapi
croup
despit
absenc
object
evid
efficaci
patient
evid
use
humidif
includ
fact
inspir
air
normal
becom
complet
satur
reach
littl
addit
nebul
fluid
therefor
pass
beyond
small
clinic
trial
n
patient
hospit
viral
croup
report
improv
outcom
measur
transcutan
oxygen
carbon
dioxid
croup
score
group
treat
humidif
compar
control
group
hour
separ
smaller
studi
n
found
differ
respiratori
resist
minut
therapi
ml
nebul
geelho
report
children
hospit
admit
case
croup
per
year
use
mist
therapi
mani
year
lack
object
evid
support
use
review
treatment
croup
conclud
although
evid
use
humidifi
air
hospit
croup
patient
anecdot
evid
suggest
use
mist
tent
unreason
long
well
toler
child
henrym
describ
use
warm
moist
atmospher
reason
least
harmless
step
like
use
hot
mist
cold
mist
mist
continu
debat
forese
futur
hot
cool
mist
tent
caus
discomfort
damp
io
l
n
mist
tent
also
interfer
visual
monitor
child
child
becom
uncomfort
kept
mist
home
offic
hospit
potenti
benefit
may
far
outweigh
increas
agit
choos
site
child
comfort
eg
arm
parent
compar
confin
mist
tent
fill
cool
warm
mist
import
overlook
intervent
humidifi
use
home
cold
humidifi
often
recommend
avoid
risk
burn
small
children
addit
famili
conduct
regular
clean
mainten
humidifi
prevent
growth
bacteria
publish
c
c
us
use
corticosteroid
relat
agent
croup
avail
earli
nilsson
oo
w
report
use
corticosteroid
croup
base
favor
experi
corton
variou
condit
intox
shock
time
agent
believ
work
antiexud
shockinhibit
forti
year
later
exact
mechan
action
corticosteroid
croup
remain
unclear
although
mani
effect
theoriz
benefit
may
mediat
reduct
local
inflammatori
reaction
includ
lymphoid
tissu
capillari
permeabl
result
decreas
subglott
edema
addit
corticosteroid
may
block
allerg
immunolog
rapid
corticosteroid
report
act
studi
suggest
undescrib
mechan
also
may
respons
random
placebocontrol
studi
martensson
et
report
signific
improv
children
treat
oral
corticosteroid
prednisolon
croup
controversi
exist
howev
subsequ
prospect
trial
yield
mix
resultsi
studi
shown
improv
follow
corticosteroid
administr
compar
placebo
tunnessen
cite
sever
reason
controversi
corticosteroid
use
conflict
studi
result
reason
includ
lack
complet
diagnost
classif
specif
differenti
viral
spasmod
croup
inadequ
dose
regimen
lack
clinic
relev
outcom
later
studi
tri
address
least
one
concern
specif
compar
patient
spasmod
croup
acut
laryngotrach
sole
outcom
measur
respiratori
rate
sleep
observ
period
follow
administr
dexamethason
placebo
differ
note
dexamethason
recipi
control
combin
group
spasmod
croup
acut
laryngotrach
acut
laryngotracheitisalon
group
analyz
separ
howev
patient
spasmod
croup
receiv
dexamethason
significantli
lower
respiratori
rate
control
kairi
et
report
metaanalysi
nine
random
studi
publish
english
languag
literatur
repres
total
patient
author
conclud
administr
corticosteroid
associ
significantli
greater
clinic
improv
hour
treatment
treatment
versu
control
versu
hour
versu
hour
likewis
incid
endotrach
intub
reduc
approxim
treatment
versu
control
corticosteroid
treat
group
sinc
metaanalysi
publish
even
recent
prospect
studi
shown
similar
effect
intub
super
et
p
show
improv
croup
score
hour
reduc
requir
racem
epinephrin
hour
durat
hospit
along
oxygen
satur
respiratori
rate
hour
significantli
better
tibbal
et
show
reduct
intub
requir
reintub
prednisolonetr
patient
kairi
et
metaanalysi
nine
random
studi
separ
low
dose
mg
cortison
equival
high
dose
mg
cortison
equival
group
although
specif
agent
eg
dexamethason
prednisolon
methylprednisolon
dosag
recommend
author
state
appear
posit
relationship
steroid
dose
proport
subject
improv
within
hour
support
highdos
therapi
year
cite
four
six
prospect
random
doubleblind
studi
adequ
dose
dexamethason
mgkg
show
signific
benefit
suggest
intramuscular
inject
dexamethason
dose
mgkg
administ
admiss
review
literatur
conclud
routin
use
steroid
children
admit
croup
justifi
basi
avail
inform
infecti
diseas
immun
committe
canadian
paediatr
publish
statement
role
corticosteroid
hospit
patient
recommend
singl
dose
dexamethason
mgkg
parenter
intramuscular
could
use
hospit
children
sever
croup
addit
differ
steroid
prepar
differ
dose
sever
differ
rout
administr
corticosteroid
use
although
parenter
administr
subject
investig
oral
recent
nebul
agent
evalu
survey
pediatrician
famili
practition
counti
around
suni
health
scienc
center
found
almost
two
third
respond
use
parenter
rout
inpati
slightli
one
third
outpati
remaind
use
oral
rout
parenter
oral
indic
case
basi
advoc
oral
administr
altern
intramuscular
inject
cite
bioavail
oral
dexamethason
avoid
discomfort
intramuscular
injet
two
studi
oral
corticosteroid
includ
metaanalysi
kairi
et
studi
one
low
dose
mg
prednisolon
high
dose
mg
dexam
e
h
ao
n
e
corticosteroid
report
benefit
recent
show
differ
outcom
measur
patient
receiv
variou
dose
oral
dexamethason
mgkg
mgkg
mgkg
singl
oral
dose
although
placebo
group
includ
studi
research
group
report
benefit
oral
dexamethason
compar
placebo
part
earlier
inhal
steroid
croup
subject
sever
recent
investig
prospect
hospit
infant
children
treatment
group
mg
nebul
budesonid
show
signific
improv
croup
score
hour
administr
versu
improv
control
salin
group
similar
prospect
nebul
budesonid
outpati
result
reduc
croup
score
earlier
discharg
home
emerg
depart
lower
hospit
rate
seventyeight
percent
placebo
group
budesonid
group
also
receiv
dexamethason
studi
followup
howev
comparison
oral
dexamethason
versu
nebul
budesonid
versu
steroid
therapi
hospit
reveal
shorter
time
reduct
croup
score
shorter
durat
hospit
less
frequent
requir
epinephrin
hour
treatment
group
rel
placebo
group
followup
group
report
oral
dexamethason
easier
administ
nebul
budesonid
base
initi
studi
current
use
oral
dexamethason
budesonid
avail
unit
state
medic
nebul
recent
random
doubleblind
use
nebul
dexamethason
found
statist
signific
improv
croup
score
hour
improv
hour
well
hospit
rate
differ
placebo
group
howev
size
studi
n
may
limit
abil
detect
signific
differ
latter
outcom
measur
use
corticosteroid
patient
ill
enough
hospit
recent
subject
initi
investig
although
use
outpati
set
suggest
reason
therapeut
trial
prevent
subsequ
hospit
patient
moder
sever
littl
experiment
evid
support
practic
despit
use
corticosteroid
set
found
common
suni
health
scienc
center
sometim
alway
use
outpati
first
prospect
corticosteroid
outpati
croup
report
studi
singl
intramuscular
inject
dexamethason
mgkg
normal
salin
administ
patient
discharg
home
emerg
depart
followup
fewer
dexamethasonetr
patient
receiv
addit
medic
care
versu
statist
signific
parent
like
report
improv
hour
treat
group
versu
time
complet
improv
group
mean
day
howev
corticosteroid
use
patient
croup
report
virtual
advers
effect
attribut
medic
pneumonia
occur
treatment
placebo
group
clear
steroid
influenc
rate
cm
p
l
c
n
describ
anecdot
report
child
treat
steroid
experienc
progress
adenovir
pneumonia
believ
worsen
steroid
administr
case
candida
laryngotrach
report
infant
treat
corticosteroid
increas
outpati
use
system
corticosteroid
varieti
condit
eg
asthma
studi
tri
address
infecti
risk
patient
one
look
sever
varicella
defin
develop
new
lesion
day
evid
viral
diseas
extend
outsid
skin
mucou
membran
calcul
increas
risk
steroid
recipi
compar
gener
popul
lastli
similar
dose
dexamethason
mgkgd
divid
everi
hour
use
day
patient
bacteri
mening
n
two
children
experienc
hemeposit
stool
two
addit
children
episod
gastrointestin
bleed
requir
summari
mani
studi
provid
evid
support
use
corticosteroid
croup
controversi
still
exist
howev
concern
effect
clinic
signific
outcom
measur
requir
hospit
requir
subsequ
medic
visit
durat
hospit
requir
intens
care
therapi
intub
also
difficulti
relat
patient
select
includ
abil
differenti
viral
spasmod
croup
influenc
respons
variou
intervent
task
appropri
select
patient
therapi
move
research
protocol
individu
physician
offic
prospect
data
outpati
set
begin
report
onset
action
corticosteroid
believ
within
hour
reduct
croup
score
hour
common
outcom
measur
report
onset
action
system
corticosteroid
hour
well
document
although
studi
nebul
budesonid
report
benefit
earli
h
optim
number
dose
corticosteroid
rout
unknown
prospect
comparison
trial
singl
versu
multidos
long
halflif
dexamethason
rel
short
durat
symptom
typic
croup
may
favor
use
singl
administr
possibl
unproven
singl
dose
administr
also
may
reduc
risk
advers
varieti
dosag
dose
regimen
exist
pediatr
textbook
recent
recommend
dexamethason
croup
airway
edema
includ
mgkgdose
everi
hour
necessari
mgkg
singl
mgkgd
divid
everi
hour
mg
kg
singl
intramuscular
intraven
dose
like
corticosteroid
epinephrin
particularli
new
therapi
croup
publish
account
use
racem
epinephrin
treatment
infecti
postintub
croup
first
appear
anesthesia
group
primari
children
hospit
salt
lake
citi
follow
introduct
racem
epinephrin
group
report
fewer
tracheotomi
decreas
none
fewer
well
shorter
hospit
despit
increas
hospit
visit
croup
impress
debut
howev
racem
epinephrin
found
limit
prospect
placebocontrol
studi
gardner
et
fail
show
reduct
durat
hospit
tracheotomi
rate
treatment
control
group
addit
found
immedi
effect
racem
epinephrin
could
wane
minut
hour
review
cite
five
prospect
doubleblind
placebocontrol
assess
racem
epinephrin
except
gardner
et
p
conclud
racem
epinephrin
effect
reduc
symptom
airway
obstruct
suggest
gardner
et
fail
show
benefit
exclud
patient
respond
simpl
mist
rap
although
earli
studi
administ
epinephrin
intermitt
positivepressur
breath
nebul
epinephrin
shown
although
gardner
et
show
benefit
nebul
therapi
without
intermitt
positivepressur
breath
prospect
specif
compar
nebul
intermitt
positivepressur
breath
racem
epinephrin
show
similar
signific
benefit
treatment
group
recommend
nebul
ippb
administr
lack
evid
show
superior
effect
intermitt
positivepressur
breath
mechan
action
racem
epinephrin
believ
mediat
alphaadrenerg
stimul
stimul
thought
result
vasoconstrict
inflam
mucou
membran
surfac
reduct
edema
epinephrin
effect
notabl
rapid
onset
short
durat
activ
follow
inhal
improv
croup
score
seen
minut
may
decreas
time
transient
natur
racem
epinephrin
benefit
shown
mani
u
e
return
croup
score
pretreat
level
hour
patient
reason
use
racem
epinephrin
contain
levorotatori
dextrorotatori
isom
equal
amount
instead
lepinephrin
entir
clear
although
virtual
studi
croup
use
racem
epinephrin
believ
racem
epinephrin
result
less
cardiovascular
effect
includ
tachycardia
hypertens
comparison
einephrin
addit
racem
epinephrin
believ
free
rebound
vasodilatatin
although
evid
support
belief
could
found
known
activ
form
epinephrin
lisom
time
activ
diomer
reason
believ
lepinephrin
could
effect
racem
epinephrin
waisman
et
compar
racem
epinephrin
lepinephrin
random
doubleblind
studi
children
acut
laryngotrach
studi
show
similar
improv
croup
score
respiratori
rate
treatment
group
differ
heart
rate
blood
pressur
record
two
group
base
one
studi
author
recommend
lepinephrin
altern
racem
epinephrin
addit
benefit
greater
avail
lower
cost
one
earliest
studi
racem
epinephrin
use
viral
croup
includ
report
success
result
emerg
depart
set
adair
et
report
discharg
home
almost
one
third
patient
emerg
depart
follow
treatment
racem
epinephrin
specif
detail
patient
select
degre
improv
durat
observ
follow
therapi
followup
outcom
given
patient
discharg
home
howev
short
durat
activ
risk
rebound
worsen
note
hospit
close
observ
recommend
patient
receiv
racem
recent
studi
howev
renew
interest
possibl
outpati
manag
select
patient
follow
administr
racem
retrospect
patient
receiv
racem
epinephrin
corticosteroid
report
patient
requir
addit
medic
care
within
hour
follow
observ
hour
lost
followup
two
prospect
td
e
attempt
identifi
patient
could
discharg
home
follow
treatment
racem
epinephrin
dexamethason
combin
studi
slightli
half
patient
qualifi
discharg
home
follow
hour
observ
patient
discharg
home
patient
return
hour
followup
period
studi
past
year
look
individu
corticosteroid
use
racem
epinephrin
use
croup
rapid
onset
short
durat
racem
epinephrin
slower
onset
longer
durat
corticosteroid
would
appear
make
potenti
use
combin
sinc
sever
u
e
report
result
combin
therapi
studi
outpati
administr
racem
epinephrin
mention
use
combin
therapi
one
hospit
croup
spasmod
croup
patient
creat
four
differ
treatment
group
use
variou
combin
intramuscular
dexamethason
mgkg
nebul
racem
epinephrin
intermitt
positivepressur
breath
dexamethason
racem
epinephrin
dexamethason
without
racem
epinephrin
racem
epinephrin
without
dexamethason
group
without
either
therapi
therapi
group
dexamethason
racem
epinephrin
show
greater
improv
comparison
placebo
group
children
receiv
dexamethason
racem
epinephrin
discharg
home
slightli
sooner
dexamethasonealon
group
k
hour
versu
hour
literatur
unclear
widespread
use
racem
epinephrin
patient
discharg
home
emerg
depart
privat
offic
set
use
outpati
therapi
would
requir
care
patient
select
period
observ
medic
facil
follow
administr
racem
epinephrin
close
followup
recent
salt
lake
citi
depart
initi
describ
epinephrin
use
croup
recommend
observ
hour
observedoutpati
administr
racem
epinephrin
expert
caution
use
racem
epinephrin
outpati
manag
report
use
adrenerg
agonist
center
mostli
around
use
racem
epinephrin
limit
data
adrenerg
agonist
includ
select
alphaadrenerg
agonist
base
theori
nebul
epinephrin
activ
may
mediat
alphaadrenerg
stimul
rather
alpha
beta
one
use
nebul
phenylephrin
small
sampl
n
hospit
children
croup
treatment
phenylephrin
result
reduct
total
respiratori
resist
seven
eight
patient
sole
nonrespond
subsequ
grew
h
infuenza
blood
throat
cultur
rang
minut
later
initi
improv
follow
rebound
increas
airway
resist
minut
therapi
author
could
recommend
use
nebul
phenylephrin
croup
although
suggest
oral
alphaadrenerg
agent
may
use
other
discuss
possibl
benefit
oral
ephedrin
pseudoephedrin
treatment
viral
croup
spasmod
outsid
singl
anecdot
success
oral
pseudoephedrin
viral
croup
howev
evid
could
found
english
languag
literatur
decis
administ
antibiot
croup
undoubtedli
influenc
patient
sever
ill
well
physician
suspicion
bacteri
infect
acut
ltb
observ
first
half
centuri
bacteri
infect
diphtherit
nondiphtherit
associ
signific
morbid
mortal
antibiot
avail
initi
sulfabas
subsequ
penicillin
soon
becam
essenti
part
therapi
lifethreaten
infect
variou
factor
alreadi
discuss
result
appreci
chang
microbiolog
croup
croup
commonli
encount
physician
today
predominantli
viral
infect
continu
administr
antibiot
children
croup
common
howev
despit
realiz
admonit
limit
physician
may
feel
oblig
consid
antibiot
concern
prevent
treat
bacteri
infect
superinfect
although
case
seri
bacteri
tracheiti
reemerg
past
decad
still
uncommon
entiti
may
distinguish
characterist
viral
croup
see
follow
discuss
also
r
e
p
r
use
prophylact
antibiot
presum
viral
uri
shown
benefit
conclus
metaanalysi
random
control
trial
antibiot
use
uri
prevent
lower
respiratori
infect
show
shorten
durat
urt
prevent
develop
pneumonia
compar
antibiot
use
croup
three
differ
hospit
children
hospit
urban
gener
hospit
rural
commun
hospit
found
inappropri
use
vari
children
hospit
urban
hospit
commun
hospit
increas
morbid
report
children
hospit
antibiot
usag
lowest
similarli
anoth
show
differ
outcom
viral
croup
follow
implement
educ
program
reduc
antibiot
use
gener
e
x
p
e
r
agre
antibiot
indic
routin
treatment
viral
croup
rate
morbid
mortal
croup
decreas
overal
centuri
comparison
current
rate
figur
begin
centuri
confound
differ
clinic
entiti
describ
croup
syndrom
epiglott
bacteri
tracheiti
viral
laryngotracheobronch
addit
mani
new
therapi
introduc
centuri
eg
immun
racem
epinephrin
corticosteroid
diphtheria
antitoxin
antibiot
intub
techniqu
also
influenc
outcom
croup
syndrom
rel
recent
epidemiolog
studi
small
percent
patient
viral
croup
requir
hospit
although
report
rang
outpati
popul
review
croup
report
hospit
rate
less
hospit
patient
estim
less
hospit
patient
requir
servic
icu
less
requir
n
u
b
recent
report
croup
case
singl
hospit
period
end
decemb
show
decreas
patient
admit
icu
decreas
intub
despit
increas
emerg
depart
visit
total
hospit
admiss
corticosteroid
nebul
epinephrin
use
increas
studi
center
time
period
increas
intub
rate
report
author
may
reflect
increas
incid
bacteri
croup
seen
certain
mortal
rate
patient
hospit
croup
previous
report
yo
summari
viral
croup
common
clinic
diagnosi
character
hoars
cri
barki
cough
stridor
addit
laboratori
test
usual
requir
assist
diagnosi
treatment
typic
case
primari
care
physician
face
challeng
select
appropri
therapi
patient
decis
made
difficult
increas
number
avail
therapi
controversi
surround
therapi
viral
croup
humidif
signific
anecdot
support
probabl
littl
risk
toler
well
patient
dexamethason
singl
dose
mgkg
administ
parenter
support
clinic
research
likewis
racem
epinephrin
reduc
symptom
acut
risk
rebound
hour
later
combin
modif
therapi
includ
dosag
rout
corticosteroid
use
lepinephrin
place
racem
epinephrin
probabl
continu
gener
interest
use
therapi
outpati
clinic
requir
physician
focu
optim
patient
select
extend
observ
period
need
close
followup
left
individu
physician
select
appropri
therapi
base
understand
scientif
literatur
well
person
experi
expertis
addit
diseas
sever
import
patient
factor
proxim
medic
care
access
car
telephon
complianc
observ
skill
famili
underestim
potenti
risk
benefit
intervent
need
consid
case
case
basi
tabl
f
l
e
ih
e
r
suggest
manag
strategi
determin
total
score
croup
score
system
taussig
understand
bacteri
croup
bacteri
tracheiti
begin
well
twentieth
centuri
avail
diphtheria
antitoxin
antibiot
laryng
diphtheria
synonym
croup
baum
credit
one
earliest
descript
acut
nondiphtherit
publish
j
diseas
describ
almost
year
ago
includ
case
similar
modern
descript
bacteri
tracheiti
report
sever
diseas
case
requir
airway
manag
death
gluelik
secret
note
tracheobronchi
airway
streptococcu
isol
case
author
familiar
diphtherit
nondiphtherit
ltb
report
similar
clinic
manifest
two
condit
l
charact
tracheal
exud
differ
howev
diphtheria
produc
fibrin
exud
compar
inflammatori
product
ltb
advent
antibiot
mortal
rate
nondiphtherit
ltb
significantli
higher
mortal
associ
laryng
bacteri
ltb
seem
diseas
appear
disappear
reappear
centuri
appear
bacteri
ltb
earli
centuri
accompani
debat
whether
condit
newli
describ
exist
previous
along
diphtherit
infect
despit
serious
littl
mention
bacteri
ltb
textbook
time
increas
number
report
mostli
otolaryngolog
literatur
publish
second
half
centuri
report
bacteri
ltb
disappear
otolaryngolog
l
e
r
tr
e
link
disappear
use
antibiot
inflammatori
pediatr
airway
diseas
fifti
year
later
debat
renew
report
bacteri
infect
upper
airway
children
reemerg
current
gener
agreement
bacteri
tracheiti
membran
pseudomembran
ltb
repres
singl
clinic
entiti
redescrib
terminolog
area
split
endoscopicpatholog
eg
membran
pseudomembran
ltb
classif
microbiolog
eg
bacteri
tracheiti
classif
han
et
describ
condit
term
membran
ltb
year
jone
et
coin
term
bacteri
tracheiti
two
separ
case
seri
almost
certainli
describ
condit
whose
distinguish
characterist
inflammatori
exud
usual
associ
isol
pathogen
bacteria
compar
report
use
endoscopicpatholog
versu
microbiolog
nomenclatur
princip
differ
isol
rate
bacteri
organ
studi
report
membran
pseudomembran
ltb
like
includ
case
bacteri
agent
isol
definit
report
bacteri
tracheiti
includ
case
bacteri
agent
identifi
gram
stain
cultur
purpos
review
inform
present
obtain
largest
seri
bacteri
tracheiti
publish
sinc
n
seri
repres
retrospect
report
case
seen
vari
length
time
past
decad
nine
seri
n
age
individu
patient
includ
age
rang
vari
week
year
old
twentyon
children
younger
year
old
year
old
year
old
year
old
older
year
old
overal
children
preschool
age
group
one
third
patient
younger
year
old
almost
two
third
younger
year
old
similar
viral
croup
case
bacteri
tracheiti
frequent
boy
girl
studiest
n
ratio
boy
girl
l
studi
report
femal
predomin
girl
boy
host
local
system
effect
may
contribut
develop
bacteri
tracheiti
break
respiratori
epithelium
loss
ciliari
function
impair
local
host
defens
wherea
viral
infect
may
interfer
system
cellular
immun
function
addit
virus
bacteria
may
interact
aid
mutual
dissemin
multipl
host
acquisit
number
specif
evid
viral
involv
bacteri
adher
mucou
opportunist
adher
use
describ
abil
pseudomona
aeruginosa
adher
mous
tracheal
epithelium
follow
infect
influenza
viru
although
exact
pathogenesi
bacteri
tracheiti
unknown
hypothes
includ
primari
bacteri
primari
viral
infect
bacteri
superinfect
bacteri
viral
coinfect
sever
viral
infect
bacteri
colon
concept
bacteri
tracheiti
complic
viral
croup
p
rpn
e
n
support
hypothesi
base
patient
viral
bacteri
agent
isol
tracheal
cultur
condit
besid
viral
infect
associ
bacteri
tracheiti
bacteri
tracheiti
report
complic
airway
procedur
includ
intub
local
tissu
injuri
induc
endotrach
tube
may
allow
bacteri
adher
trachea
manner
viral
infect
model
shown
ferret
follow
endotrach
intub
host
condit
syndrom
may
predispos
bacteri
tracheiti
three
td
e
report
total
seven
patient
syndrom
defect
cellular
humor
immun
well
anatom
abnorm
airway
may
result
higher
incid
bacteri
tracheiti
patient
streptococcu
predomin
agent
isol
bacteri
ltb
first
half
e
n
u
r
studi
includ
review
clinic
manifest
bacteri
tracheiti
combin
featur
viral
croup
epiglott
viral
croup
prodrom
viral
uri
may
preced
symptom
hour
day
e
e
k
symptom
follow
develop
barki
cough
evid
increas
upper
airway
obstruct
higher
fever
greater
degre
toxic
seen
patient
bacteri
tracheiti
may
favor
diagnosi
epiglott
viral
croup
presenc
barki
cough
bacteri
tracheiti
may
primari
distinguish
factor
epigltt
addit
patient
bacteri
tracheiti
tend
longer
durat
less
frequent
compar
epiglott
respiratori
distress
progress
rapidli
point
complet
airway
compromis
cardiorespiratori
arrest
viral
croup
blood
test
provid
littl
addit
inform
case
seri
review
wbc
count
gener
rang
anywher
normal
moder
elev
mean
wbc
five
u
e
mani
td
e
note
predomin
polymorphonuclear
refer
trefer
cell
immatur
neutrophil
mean
neutrophil
count
four
n
mean
band
count
three
td
e
n
crp
level
report
one
reveal
patient
normal
valu
patient
abnorm
crp
valu
show
mark
elev
although
patient
blood
cultur
perform
eight
studi
combin
report
posit
blood
patient
cultur
remain
seven
studi
w
posit
blood
cultur
h
influenza
report
neck
roentgenogram
usual
abnorm
nine
studiest
patient
show
evid
subglott
narrow
find
includ
evid
intratrach
membran
evidenc
opaqu
streak
irregular
margin
later
neck
enlarg
epiglotti
patient
chest
radiograph
abnorm
almost
half
case
rang
find
includ
interstiti
infiltr
linear
densiti
bronchiti
bronchopneumonia
pulmonari
edema
hyperinfl
pneumon
pneumonia
gener
definit
diagnosi
bacteri
tracheiti
made
direct
visual
suggest
way
distinguish
bacteri
tracheiti
laryngoscopi
bronchoscopi
therapeut
diagnost
purul
exud
block
airway
remov
submit
examin
gram
stain
materi
reveal
wbc
bacteria
good
correl
gram
stain
bacteri
cultur
result
microbiolog
test
import
confirm
etiolog
agent
select
modifi
antibiot
therapi
result
viral
bacteri
cultur
review
previous
clinic
respons
treatment
racem
epinephrin
also
may
help
distinguish
viral
croup
bacteri
tracheiti
patient
mani
comment
lack
improv
follow
administr
inhal
racem
epinephrin
patient
bacteri
tracheiti
effect
racem
epinephrin
patient
viral
croup
alreadi
discuss
sixti
year
ago
jackson
jacksongo
emphas
cool
humidifi
air
rest
bacteri
ltb
gener
therapi
use
viral
croup
use
initi
therapi
bacteri
tracheiti
therapi
bacteri
tracheiti
may
notabl
failur
howev
success
td
e
review
patient
almost
univers
unrespons
tradit
medic
therapi
use
viral
croup
includ
humidif
racem
epinephrin
one
report
signific
initi
improv
racem
epinephrin
although
almost
half
respond
becam
unrespons
continu
aerosol
therapi
jone
et
suggest
accumul
secret
trachea
may
prevent
nebul
epinephrin
reach
mucos
surfac
affect
area
studi
emphas
import
airway
manag
bacteri
tracheiti
intub
tracheostomi
necessari
major
patient
studi
intub
perform
patient
tracheostomi
patient
intervent
major
patient
manag
without
artifici
airway
studi
patient
requir
intub
none
requir
tracheostomi
prefer
intub
versu
tracheostomi
may
center
depend
studi
tracheostomi
report
seri
two
center
respons
tracheotomi
g
r
op
report
eas
remov
tracheal
secret
follow
tracheostomi
parenter
antibiot
administ
cover
common
etiolog
bacteri
tracheiti
like
repres
superinfect
viral
croup
aureu
streptococc
sp
h
influenza
commonli
isol
organ
earli
symptom
mimic
viral
croup
howev
subsequ
cours
typic
sever
suggest
epiglott
respiratori
symptom
gener
amen
convent
therapi
viral
croup
includ
humidif
racem
epinephrin
close
monitor
airway
princip
therapi
intub
tracheotomi
usual
requir
prevent
obstruct
purul
exud
trachea
antibiot
therapi
direct
toward
like
pathogen
overlap
symptom
viral
croup
physician
need
consid
bacteri
tracheiti
differenti
diagnosi
children
stridor
suspicion
even
higher
children
appear
unusu
ill
fail
respond
usual
medic
therapi
croup
refer
refer
definit
bronchiti
repres
inflamm
bronchi
part
contigu
structur
make
respiratori
kact
reason
believ
bronchi
immun
infect
inflamm
unfortun
step
histopatholog
definit
clinic
definit
easi
one
term
croup
bronchiti
probabl
encompass
mani
separ
clinic
entiti
unlik
croup
bronchiti
lack
characterist
clinic
featur
separ
inflammatori
condit
involv
part
respiratori
tract
addit
clinic
manifest
usual
sever
enough
warrant
addit
diagnost
studi
confirmatori
test
eg
bronchoscopi
major
patient
factor
result
inabl
creat
simpl
effect
clinic
definit
factor
along
possibl
misus
overus
term
physician
famili
result
acut
bronchiti
becom
poorli
understood
diagnosi
commonli
bronchiti
separ
acut
chronic
recurr
form
classif
system
impli
airway
hyperreact
wheezi
bronchiti
asthmat
bronchiti
infecti
asthma
base
part
qualiti
sputum
catarrh
suppur
plastic
bronhiti
acknowledg
limit
current
inform
discuss
aim
primarili
acut
infecti
bronchiti
data
collect
nation
ambulatori
care
survey
report
offic
visit
children
younger
year
age
result
diagnosi
bronchiti
although
report
separ
visit
acut
chronic
bronchiti
frequenc
visit
made
bronchiti
slightli
less
common
nonsuppur
otiti
media
slightli
common
asthma
bronchiti
repres
visit
age
group
chapel
hill
pediatr
g
r
op
studi
incid
croup
also
collect
epidemiolog
data
lower
respiratori
tract
infect
includ
tracheobronch
studi
period
case
lower
respiratori
tract
diseas
classifi
tracheobronch
followup
reporp
chapel
hill
tracheobronch
continu
common
bronchiol
pneumonia
croup
tracheobronch
rate
highest
first
year
life
combin
attack
rate
boy
girl
per
children
per
year
occur
year
overal
rate
boy
higher
girl
rel
risk
younger
children
year
old
rel
risk
even
higher
wherea
effect
gender
decreas
age
boy
girl
virtual
equal
attack
rate
data
unit
kingdom
also
show
highest
attack
rate
acut
bronchiti
children
younger
year
old
although
data
gender
distribut
aailabl
season
tracheobronch
rate
peak
winter
month
nadir
sm
e
r
peak
month
younger
children
januari
februari
march
older
children
start
month
earlier
decemb
januari
februari
peak
month
younger
children
correspond
primarili
rsv
parainfluenza
influenza
season
peak
time
older
children
correspond
mostli
influenza
mycoplasma
outbreak
occasion
rsv
parainfluenza
season
preval
winter
nadir
august
also
report
unit
k
n
g
dm
indepth
discuss
chronic
recurr
bronchiti
beyond
scope
articl
data
chapel
hill
recurr
episod
tracheobronch
made
total
case
two
episod
three
episod
although
conceptu
similar
spasmodicrecurr
croup
chronic
recurr
bronchiti
suffer
problem
definit
diagnosi
acut
bronchiti
one
major
diagnost
problem
consider
overlap
chronic
recurr
bronchiti
childhood
asthma
earli
epidemiolog
r
e
pr
bronchiti
may
includ
episod
acut
asthma
sever
epidemiolog
survey
unit
state
unit
kingdom
investig
chang
frequenc
asthma
bronchiti
diagnos
rate
diagnos
increas
period
review
royal
colleg
gener
practition
communic
diseas
surveil
centr
public
health
laboratori
base
simultan
increas
author
suggest
rise
asthma
rate
recent
year
real
result
chang
diagnost
label
contrast
hospit
discharg
rate
collect
nation
hospit
discharg
show
increas
asthma
admiss
decreas
bronchiti
admiss
specul
recent
increas
asthma
incid
result
willing
part
health
care
worker
diagnos
asthma
children
suggest
primari
care
physician
may
use
diagnosi
bronchiti
way
avoid
label
child
asthma
infect
especi
viral
airway
hyperreact
may
play
central
role
produc
similar
clinic
manifest
condit
episod
acut
bronchiti
children
primarili
viral
infect
see
follow
discuss
addit
viral
infect
may
respons
initi
episod
chronic
recurr
bronchiti
similarli
increas
interest
document
role
virus
exacerb
asthma
recent
schoolag
children
use
sophist
viral
detect
techniqu
eg
polymeras
chain
reaction
immunofluoresc
serolog
determin
often
respiratori
viral
infect
accompani
exacerb
asthma
children
complet
longitudin
studi
common
cold
virus
eg
rhinoviru
coronaviru
detect
asthma
exacerb
possibl
chronic
recurr
bronchiti
manifest
spectrum
childhood
h
therapeut
possibl
close
relationship
recurr
chronic
bronchiti
asthma
trial
bronchodil
therapi
may
major
episod
acut
bronchiti
children
thought
viral
caus
american
thorac
includ
acut
tracheobronch
head
clinic
syndrom
known
viral
etiolog
case
bronchiti
fall
mirror
isol
parainfluenza
commun
wherea
winter
rise
bronchiti
parallel
rise
rsv
influenza
case
tracheobronch
chapel
hill
studi
agent
isol
includ
virus
pneumonia
ten
although
report
chapel
hill
data
measl
also
associ
acut
bronhiti
rhinoviru
report
commonli
identifi
agent
children
recurr
episod
acut
wheezi
bronchiti
outpati
clinic
repres
isol
one
isol
anoth
studi
group
associ
rhinoviru
exacerb
asthma
alreadi
unlik
parainfluenza
influenza
rsv
rhinovirus
adenovirus
shown
season
pattern
epidemiolog
age
patient
influenc
likelihood
particular
agent
caus
bronchiti
rsv
parainfluenza
predomin
agent
younger
children
wherea
mycoplasma
tend
occur
older
children
rsv
repres
isol
children
year
old
wherea
repres
case
children
year
older
similarli
parainfluenza
type
repres
isol
children
year
old
children
year
older
adenoviru
also
declin
incid
age
mycoplasma
rate
increas
increas
age
wherea
influenza
rate
remain
rel
constant
throughout
age
group
mycoplasma
influenza
repres
isol
children
year
older
show
propens
olderag
children
half
mycoplasma
isol
occur
children
year
older
almost
occur
children
year
older
chlamydia
pneumonia
recent
identifi
patient
bronchiti
adolesc
adult
popul
univers
washington
seattl
washington
c
pneumonia
respons
case
pneumonia
viral
agent
includ
influenza
b
rsv
adenoviru
made
respect
case
studi
remain
patient
list
unspecifi
group
bacteri
tracheiti
bacteri
bronchiti
may
follow
local
break
respiratori
epithelium
includ
effect
primari
viral
suspect
bacteri
agent
includ
pneumonia
aureu
h
influenza
catarrhali
primari
bacteri
infect
seen
bordatella
pertussi
coynebacterium
gener
attempt
clinic
classif
acut
respiratori
ill
difficult
primarili
overlap
clinic
sign
symptom
acut
bronchiti
bronchiol
pneumonia
particular
may
share
symptom
complex
includ
cough
fever
suggest
dyspnea
rapid
respir
chest
radiograph
abnorm
may
help
distinguish
bronchiol
pneumonia
bronchiti
recent
attempt
compar
children
diagnos
acut
bronchiti
firsttim
asthma
uri
cough
histori
sputum
product
presenc
rale
rhonchi
examin
associ
commonli
diagnosi
bronchiti
characterist
present
slightli
one
third
patient
howev
sign
absent
patient
addit
respiratori
tract
infect
airway
hyperreact
irrit
exposur
eg
pollut
gastric
acid
may
mimic
acut
infecti
acut
bronchiti
would
appear
lie
symptomat
anatom
viral
uri
pneumonia
chapel
hill
bronchiti
tracheobronch
defin
respiratori
ill
character
deep
cough
rhonchi
audibl
larger
airway
bronchiti
describ
ill
begin
symptom
mild
viral
uri
includ
fever
rhiniti
nonproduct
n
cough
progress
becom
product
older
patient
may
report
chest
cough
typic
last
less
week
primari
time
symptom
auscult
wheez
refer
breath
sound
may
detect
one
report
found
wheez
present
twice
often
two
third
case
patient
diagnos
bronchiti
compar
bronchiol
pneumonia
everi
step
discuss
confound
lack
clear
clinic
definit
ill
consid
clinic
primari
care
physician
reliabl
tool
histori
physic
examin
better
aim
rule
condit
confirm
diagnosi
bronchiti
primari
symptom
cough
pathognomon
physic
find
lack
common
screen
laboratori
test
nondiagnost
clinic
littl
avail
physician
help
local
quantifi
degre
inflamm
bronchi
nonspecif
test
distinguish
viral
versu
bacteri
infect
wbc
count
crp
discuss
section
markedli
elev
neutrophil
count
crp
could
increas
suspicion
bacteri
caus
viral
studi
includ
antigen
test
serolog
cultur
superfici
deep
nasopharyng
specimen
may
support
specif
etiolog
agent
test
mycoplasma
cold
agglutinin
pneumonia
titer
acut
convalesc
wide
avail
wherea
test
c
pneumonia
limit
avail
bacteria
uncommonli
report
caus
acut
bronchiti
children
obtain
suitabl
specimen
gram
stain
bacteri
cultur
difficult
smaller
children
gener
nonspecif
screen
test
cbc
crp
along
specif
microbiolog
studi
may
indic
typic
addit
result
test
eg
pair
sera
may
becom
avail
symptom
expect
resolv
chest
radiograph
bronchiti
although
peribronchi
thicken
may
radiograph
may
help
rule
presenc
anoth
lower
respiratori
tract
diseas
support
diagnosi
bronchi
ti
uncommon
patient
would
ill
enough
requir
hospit
fewer
still
would
requir
bronchoscopi
verifi
diagnosi
document
inflamm
bronchi
acut
bronchiti
laboratori
test
may
indic
case
unusu
sever
persist
symptom
epidemiolog
factor
may
suggest
bacteri
agent
base
data
review
bronchiti
easi
diagnosi
make
difficult
diagnosi
confirm
result
difficulti
confirm
diagnosi
acut
infecti
bronchiti
prospect
data
exist
effect
variou
treatment
outcom
pediatr
age
group
commonli
simpl
support
measur
advoc
viral
respiratori
infect
rest
hydrat
humidif
avoid
environment
irrit
eg
smoke
often
mainstay
american
academi
advis
use
cough
suppress
includ
dextromethorphan
codein
individu
product
cough
limit
use
patient
nonproduct
cough
eg
case
vomit
mark
sleep
disturb
patient
wheez
signific
compon
may
benefit
antivir
agent
may
indic
certain
sever
one
challeng
question
clinician
ever
antibiot
indic
base
epidemiolog
data
alreadi
present
larg
major
identifi
infect
patient
famili
physician
may
inclin
toward
antibiot
administr
someon
product
cough
howev
addit
pneumonia
identifi
older
children
acut
suggest
diagnos
bronchiti
may
method
justifi
antibiot
therapi
help
explain
children
diagnos
bronchiti
treat
antibiot
one
ep
e
r
uniformli
oppos
use
antibiot
usual
uncompl
case
bronchiti
minor
case
nonvir
caus
strongli
suspect
empir
therapi
begun
may
case
p
rm
n
e
n
recurr
case
symptom
persist
without
improv
e
e
k
risk
infect
pneumonia
may
increas
older
children
commun
outbreak
g
c
recommend
erythromycin
reason
empir
therapi
bacteri
infect
suspect
although
feigin
report
treatment
pneumonia
usual
show
impress
respons
consid
persist
cough
may
indic
airway
hyperreact
rather
bacteri
infect
superinfect
unfortun
lack
data
therapi
includ
antibiot
influenc
sever
durat
symptom
acut
bronchiti
acut
bronchiti
sever
enough
requir
hospit
uncommon
compar
frequenc
diagnosi
made
compar
mean
annual
attack
rate
hospit
data
unit
kingdom
hospit
rate
acut
bronchiti
estim
less
author
state
acut
bronchiti
common
ill
manag
larg
gener
practition
specif
morbid
mortal
data
would
requir
clearer
clinic
definit
studi
acut
bronchiti
limit
serious
lack
clinic
definit
diagnosi
infecti
process
primarili
isol
bronchi
difficult
confirm
outpati
clinic
sign
symptom
well
typic
screen
laboratori
test
eg
cbc
crp
nonspecif
invas
diagnost
procedur
eg
bronchoscopi
unreason
case
typic
benign
selflimit
data
exist
acut
bronchiti
often
result
viral
infect
e
g
rsv
parainfluenza
influenza
virus
patient
diagnosi
made
therefor
therapi
gener
support
antibiot
therapi
probabl
indic
case
unusu
prolong
sever
